PARIS & SAN FRANCISCO–(BUSINESS WIRE)–SpineGuard (FR0011464452 – ALSGD), an innovative company that designs, develops and markets disposable medical devices intended to make spine surgery safer, reported today that its first-quarter 2015 revenue grew by 47%, to € 1.5 million.
Pierre Jérôme, CEO of SpineGuard, said: “We are very pleased with the strong growth delivered in the first quarter of 2015, even excluding the benefit of a strengthening dollar. Our targeted sales efforts, clinico-economic data and marketing initiatives are bearing fruit, particularly in the USA and France. Our performance in those two direct markets represents more than 75% of our revenue and aptly reflects the dynamism of our business. The company continues to vigorously drive sales of the PediGuard® range to sustain solid growth this year. In addition, we are progressing rapidly with our smart screw partners to help them differentiate their products, expand the value of our DSG™ platform, and trigger new sources of revenue for SpineGuard.”
Revenue in the United States increased 58.8% (30.4% cc) to €1,123k in the first quarter of 2015, compared with €707k in the first quarter of 2014, and represented 74% of global revenue. In the rest of the world, revenue increased 20.2% during the first quarter of 2015 to €394k compared with €328k in the first quarter of 2014, and represented 26% of global revenue. France, the company’s second direct market after the United States, reported a 36% growth in the first quarter of 2015, and represented 4% of global revenue. 
1,977 PediGuard units were sold in the first quarter of 2015 compared with 1,524 in the first quarter of 2014, including 956 in the United States, representing 48% of total units sold.